Abstract
Nanoconstructs intended to be used as biomedical tool must be assessed for their capability to cross biological barriers. However, studying in vivo the permeability of biological barriers to nanoparticles is quite difficult due to the many structural and functional factors involved. Therefore, the in vitro modeling of biological barriers - 2D cell monocultures, 2D/3D cell co-cultures, microfluidic devices- is gaining more and more relevance in nanomedical research. Microscopy techniques play a crucial role in these studies, as they allow both visualizing nanoparticles inside the biological barrier and evaluating their impact on the barrier components. This paper provides an overview of the various microscopical approaches used to investigate nanoparticle translocation through in vitro biological barrier models. The high number of scientific articles reported highlights the great contribution of the morphological and histochemical approach to the knowledge of the dynamic interactions between nanoconstructs and the living environment.
Key words: nanoconstructs, cell culture, organoid, microfluidics, bioreactor, fluorescence microscopy, electron microscopy
Introduction
One of the main issues in the development of nanoconstructs intended for biomedical purposes is the assessment of their capability to cross biological barriers. In fact, to reach their target and play therapeutic or diagnostic functions, nanoparticles (NPs) must face various barriers, not only the plasmalemma that surrounds any cells but first the more complex histological structures, which regulate the molecular traffic in specific organs or anatomical regions of the body: the skin, the endothelial, intestinal, lung or placental barriers, the blood brain barrier (BBB), or the tumor microenvironment barrier.
Studying the permeability of biological barriers to NPs is a quite difficult task to perform in vivo, due to the numerous structural and functional factors influencing the process. For this reason, in vitro modeling of biological barriers -from the simple 2D cell monocultures to 2D and 3D cell co-cultures, to the high technologic microfluidic devices- is becoming more and more popular in nanomedical research (recent review in1). By using these in vitro models, it is possible to track the NPs during their passage across the barrier, to elucidate the mechanisms involved in their dynamic interactions, and to identify the NPs’ physico-chemical features necessary to guarantee their translocation.
Microscopy techniques are crucial in these studies, as they allow both visualizing the NPs through the barrier and evaluating their impact on the barrier components. Depending on the microscopy technique used (bright-field or phase contrast microscopy, fluorescence microscopy or transmission electron microscopy), NPs can be made detectable by either linking/loading appropriate dyes during the synthetic process or by labelling with specific histochemical staining after their administration.2-16 Moreover, some nanoconstructs such as quantum dots or nanodiamonds, are characterized by an intrinsic photoluminescence that can be easily detected at fluorescence microscopy in the absence of an additional staining.17,18
This paper aims at providing an overview of the various microscopical approaches used to investigate in vitro the translocation of NPs through biological barriers, thus highlighting the great contribution of microscopy techniques to the knowledge of the interactions between the living environment and the nanoconstructs.
Tracking nanoparticles across biological barriers
Fluorescence microscopy is the most widely used technique to analyse NPs translocation through biological barrier models. Among the different fluorescent-related microscopy techniques, laser scanning confocal microscopy (LSCM) is extensively applied because, compared to the conventional epifluorescence microscopy, it provides an increase in the effective signal-to-noise ratio and allows visualizing the 3D distribution of NPs by the collection of serial optical sections from the entire sample thickness.19
Numerous works have exploited the potential of LSCM to detect the uptake, diffusion and localization of several kind of NPs through different biological barriers (blood vessel, skin, intestine, mucus, tumor) simulated in vitro under static or dynamic conditions. 20-33 George and collaborators investigated the translocation of silica NPs in a transwell model of the human bronchial epithelial barrier, obtaining also quantitative information on the NP distribution in the apical and basolateral compartments.34 Similarly, Schimpel and colleagues35 performed a z-stack scan to demonstrate a highest particle uptake in the double culture model of Caco-2 cells (immortalized cell line of human colorectal adenocarcinoma) and Microfold (M) cells, compared to Caco-2 monolayer and Caco-2/HT29-MTX triple culture as in vitro models of the intestinal barrier.
LSCM was also used to visualize the adhesion, accumulation and dynamic relocation of NPs in function of their geometry, size and cell type in in vitro 3D models of dermis or cerebral endothelium. 36,37 Through LSCM it was possible to perform a semi-quantitative analysis of the kinetics mechanisms of penetration through tumor barriers and accumulation of fluorescent NPs, by directly scanning 3D models or measuring the fluorescence intensity of cryosections taken either from a mid-penetration depth or from the entire thickness of the 3D matrix.38-42
Moreover, LSCM offers the possibility of optically reconstructing the barrier in 3D with extremely low out-of-focus noise and improved spatial resolution. In this context, many researchers have been using the 3D modelling, obtained from z-stacks acquisition, to visualize the spatial distribution of NPs. Moreira and collaborators investigated in 2D and 3D tumor models the distribution and effects of a novel pH- and thermo-responsive carrier composed of doxorubicin-loaded gold-core silica shell nanorods and salicylic acid loaded poly(lactic-co-glycolic acid)-based microparticles,43 while Hu and collaborators44 evaluated the penetration capability of NPs into an artificial skin model generated by the 3D bioprinting technology. Papademetriou and colleagues45 used LSCM to obtain 3D images for evaluating the internalization of Angiopep-2- coupled (Ang2)-liposomes through the brain endothelial cells using a microfluidic model of the BBB. Similarly, a 3D intensity map of a human BBB microvasculature and a tumor-on-a-chip model was obtained to quantify the gradient formation and space/time-dependent distribution of NPs.46,47
Besides LSCM, also the simpler epifluorescence microscopy proved to be a suitable technique to visualize the translocation of fluorescent NPs into different in vitro barrier models.48-53 For example, Jia and collaborators54 obtained information about the mobility of NPs in the mucus barrier. In detail, fluorescent polystyrene NPs were injected at a constant flow speed in the “lumen channel” of a mucus-on-chip device, and their transport within the mucus from the mucus-liquid interface was visualized over time using conventional fluorescence microscopy. A timelapse configuration was introduced in the microscopy system to track fluorescent NPs as they move through simulated biological barriers such as microfluidic devices of the endothelial barrier or 3D human lung-on-a-chip models.55-59 As demonstrated by Kiew and collaborators,56 conventional fluorescence microscopy also allows semi-quantitative evaluation of NPs permeability in an in vitro biomimetic microfluidic model of blood vessel.
Other light microscopy techniques have been applied for the dynamic observation of NPs through biological barriers or to determine the efficiency of NPs as suitable shuttles for pharmaceutical applications. For instance, Brancato and collaborators60 used bright-field microscopy to investigate the efficacy of polymeric NPs in reducing the diameter of 3D tumor tissue models. Optical microscopy was also used by Albanese and colleagues39 to confirm the presence of polyethylene glycol NPs inside tumor-like spheroids in a microfluidic system, by measuring the intensity of silver staining in each spheroid section. Live-cell imaging videos acquired through phase contrast microscopy allowed monitoring the passage of silica NPs across a microfluidic in vitro model of endothelium.61 The relevance of the light microscopy techniques for studying the dynamic interaction of NPs is confirmed in a study by Hudecz and collaborators,62 who obtained high-resolution imaging of the NP interactions with endothelial cells and the capture of rare NP translocation events in an in vitro BBB model using a specially designed bioreactor with ultrathin silicon membranes.
Despite the numerous advantages of light microscopy to track NPs in 2D and 3D biological barrier models, a limitation is represented by the achievable spatial resolution. In this regard, transmission electron microscopy (TEM) proved to be especially adequate to study the penetration and distribution of NPs at the sub-cellular level in tumor or atherosclerotic vessel or in epithelial airway models. 39,50,51,58,63 Stereological analysis of TEM micrographs allowed the evaluation of the number of intracellular particles in a human epithelial airway model,64 while electron spectroscopic imaging was used by Raemy and collaborators65 to localize at TEM cerium oxide NPs in the intercellular milieu of an in vitro lung barrier.
Evaluating the effects of nanoparticles on biological barriers
Microscopy is also applied to determine the effects of NPs on 2D and 3D in vitro biological barriers in order to evaluate the efficacy and potential risks associated with the administration of nanoconstructs. To this aim, fluorescence microscopy is again the most widely used technique. In several studies, the cell viability was investigated by various assays based on fluorescent dyes after NPs exposure in tumor and dermal barrier models.44,66,67 The impact on cell viability of titanium dioxide NPs in an in vitro gut epithelial model was evaluated by staining with a mixture of acridine orange and ethidium bromide.63 Moreover, the changes in cell morphology and activities were measured through fluorescence microscopy to evaluate the effect of ZnS NPs on fibroblasts cultured in a 3D wound healing model.68 To further characterize the effect of NPs penetration across biological barriers, immunofluorescence staining of specific biomarkers was also performed. As an example, the expression of junctional proteins was assessed to prove the cell integrity after NPs exposure in models of BBB,70 bronchial epithelial barrier34 and skin.69 Fluorescence microscopy was also used to evaluate the morphological changes of 3D multicellular spheroids mimicking the solid tumor barrier, after administration of doxorubicin-loaded NPs.49 Similarly, Moreira and collaborators43 investigated the capability of gold-core silica shell nanorods with salicylic acid loaded poly(lactic-co-glycolic acid) based microparticles to promote tumor cells death and spheroid disassembly; to do this, the authors monitored by light microscopy the variation in time of the spheroids size.
The morphological integrity of tissues after NPs administration was evaluated using histological staining techniques. For example, the classic hematoxylin and eosin staining was used to visualize the skin structure,53,69,71,72 the integrity of the BBB,48 and the effect of photodynamic therapy in an in vitro 3D microfluidic breast cancer tissue model.66 The effect of retinol-lipid NPs on collagen in an in vitro model of human skin was assessed by the Masson’s trichrome staining.73
Electron microscopy is also gaining relevance in determining the effectiveness of NPs in biological barrier models. In fact, Wang and colleagues74 used scanning electron microscopy images to demonstrate the antibacterial efficacy of Carbopol nanogel particles in reducing the biofilm attached on a 3D co-culture model of biofilm/human keratinocyte clusteroid.
Concluding remarks
Nanomedicine is a rapidly developing research area and represents a stimulating challenge for many scientific and technological disciplines.
The novel nanoconstructs must be characterized for their chemical nature, electric charge, size and shape, then carefully tested for biocompatibility: in this context, microscopy not only plays an irreplaceable role for the structural characterization of NPs, but is also crucial to elucidate their spatial interactions and functional effects on living organisms.
To reach their organ, tissue or cell targets, NPs must cross different and complex biological barriers, and light and electron microscopy techniques proved to be especially appropriate to visualize their dynamic behavior. The modelling of in vitro systems that mimic the physiological complexity of living structures is becoming increasingly frequent in science, to ensure controlled experimental conditions while meeting the ethic and economic issues aimed at reducing the number of the animals to be used in the research practice. The growing number of scientific papers that deal with the application of a variety of microscopy techniques to assess NPs’ crossing of in vitro biological barriers testifies the importance of the morphological and histochemical approach in this advanced research field.
Funding Statement
Funding: This work did not receive specific funding.
References
- 1.Carton F, Malatesta M. In Vitro Models of Biological Barriers for Nanomedical Research. Int J Mol Sci 2022; 23:8910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Malatesta M, Giagnacovo M, Costanzo M, Conti B, Genta I, Dorati R, et al. Diaminobenzidine photoconversion is a suitable tool for tracking the intracellular location of fluorescently labelled nanoparticles at transmission electron microscopy. Eur J Histochem 2012;56:e20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Carton F, Repellin M, Lollo G, Malatesta M. Alcian blue staining to track the intracellular fate of hyaluronic-acid-based nanoparticles at transmission electron microscopy. Eur J Histochem 2019;63:3086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Guglielmi V, Carton F, Vattemi G, Arpicco S, Stella B, Berlier G, et al. Uptake and intracellular distribution of different types of nanoparticles in primary human myoblasts and myotubes. Int J Pharm 2019;560:347-56. [DOI] [PubMed] [Google Scholar]
- 5.Kim D, Jeong K, Kwon JE, Park H, Lee S, Kim S, et al. Dualcolor fluorescent nanoparticles showing perfect color-specific photoswitching for bioimaging and super-resolution microscopy. Nat Commun 2019;10:3089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mannucci S, Boschi F, Cisterna B, Esposito E, Cortesi R, Nastruzzi C, et al. A Correlative imaging study of in vivo and ex vivo biodistribution of solid lipid nanoparticles. Int J Nanomedicine 2020;15:1745-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Costanzo M, Esposito E, Sguizzato M, Lacavalla MA, Drechsler M, Valacchi G, et al. Formulative study and intracellular fate evaluation of ethosomes and transethosomes for Vitamin D3 delivery. Int J Mol Sci 2021;22:5341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Malatesta M. Transmission electron microscopy as a powerful tool to investigate the interaction of nanoparticles with subcellular structures. Int J Mol Sci 2021;22:12789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Malatesta M. Histochemistry for nanomedicine: Novelty in tradition. Eur J Histochem 2021;65:3376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Yang G, Liu Y, Zhao CX. Quantitative comparison of different fluorescent dye-loaded nanoparticles. Colloids Surf B Biointerfaces 2021;206:111923. [DOI] [PubMed] [Google Scholar]
- 11.Cappellozza E, Boschi F, Sguizzato M, Esposito E, Cortesi R, Malatesta M, et al. A spectrofluorometric analysis to evaluate transcutaneous biodistribution of fluorescent nanoparticulate gel formulations. Eur J Histochem 2022;66:3321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Li W, Kaminski Schierle GS, Lei B, Liu Y, Kaminski CF. Fluorescent nanoparticles for super-resolution imaging. Chem Rev 2022;122(15):12495-543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bitonto V, Garello F, Scherberich A, Filippi M. Prussian Blue Staining to Visualize Iron Oxide Nanoparticles. Methods Mol Biol 2023;2566:321-32. [DOI] [PubMed] [Google Scholar]
- 14.Cheli F, Falsini S, Salvatici MC, Ristori S, Schiff S, Corti E, et al. Fluorescent labeling of lignin nanocapsules with fluorol yellow 088. Methods Mol Biol 2023;2566:345-53. [DOI] [PubMed] [Google Scholar]
- 15.Costanzo M, Malatesta M. Diaminobenzidine photooxidation to visualize fluorescent nanoparticles in adhering cultured cells at transmission electron microscopy. Methods Mol Biol 2023;2566:333-43. [DOI] [PubMed] [Google Scholar]
- 16.Repellin M, Carton F, Lollo G, Malatesta M. Alcian Blue staining to visualize intracellular hyaluronic acid-based nanoparticles. Methods Mol Biol 2023;2566:313-30. [DOI] [PubMed] [Google Scholar]
- 17.Matea CT, Mocan T, Tabaran F, Pop T, Mosteanu O, Puia C, et al. Quantum dots in imaging, drug delivery and sensor applications. Int J Nanomedicine 2017;12:5421-31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Boruah A, Saikia BK. Synthesis, characterization, properties, and novel applications of fluorescent nanodiamonds. J Fluoresc 2022;32:863-85. [DOI] [PubMed] [Google Scholar]
- 19.Cardellini J, Balestri A, Montis C, Berti D. Advanced static and dynamic fluorescence microscopy techniques to investigate drug delivery systems. Pharmaceutics 2021;13:861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kostarelos K, Emfietzoglou D, Papakostas A, Yang WH, Ballangrud Å, Sgouros G. Binding and Interstitial penetration of liposomes within avascular tumor spheroids. Int J Cancer 2004;112:713–21. [DOI] [PubMed] [Google Scholar]
- 21.Wojnilowicz M, Besford QA, Wu YL, Loh XJ, Braunger JA, Glab A, et al. Glycogen-nucleic acid constructs for gene silencing in multicellular tumor spheroids. Biomaterials 2018;176:34-49. [DOI] [PubMed] [Google Scholar]
- 22.Sims LB, Huss MK, Frieboes HB, Steinbach-Rankins JM. Distribution of PLGA-modified nanoparticles in 3D cell culture models of hypo-vascularized tumor tissue. J Nanobiotechnol 2017;15:67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Xu X, Sabanayagam CR, Harrington DA, Farach-Carson MC, Jia X. A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics. Biomaterials 2014;35: 3319-30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Le VM, Lang MD, Shi WB, Liu JW. A Collagen-based multicellular tumor spheroid model for evaluation of the efficiency of nanoparticle drug delivery. Artif Cells Nanomed Biotechnol 2016;44:540-4. [DOI] [PubMed] [Google Scholar]
- 25.Wang HF, Ran R, Liu Y, Hui Y, Zeng B, Chen D, et al. Tumorvasculature- on-a-chip for investigating nanoparticle extravasation and tumor accumulation. ACS Nano 2018;12:11600-9. [DOI] [PubMed] [Google Scholar]
- 26.Paek J, Park SE, Lu Q, Park KT, Cho M, Oh JM, et al. Microphysiological Engineering of self-assembled and perfusable microvascular beds for the production of vascularized three-dimensional human microtissues. ACS Nano 2019;13:7627-43. [DOI] [PubMed] [Google Scholar]
- 27.Schuerle S, Soleimany AP, Yeh T, Anand GM, Häberli M, Fleming HE, et al. Synthetic and living micropropellers for convection- enhanced nanoparticle transport. Sci Adv 2019;5:eaav4803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Bengalli R, Colantuoni A, Perelshtein I, Gedanken A, Collini M, Mantecca P, et al. In vitro skin toxicity of CuO and ZnO nanoparticles: Application in the safety assessment of antimicrobial coated textiles. NanoImpact 2021;21:100282. [DOI] [PubMed] [Google Scholar]
- 29.Kadiyala I, Loo Y, Roy K, Rice J, Leong KW. Transport of chitosan- DNA Nanoparticles in human intestinal M-cell Model versus normal intestinal enterocytes. Eur J Pharm Sci 2010;39:103-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Gullberg E, Keita AV, Salim SY, Andersson M, Caldwell KD, Söderholm JD, et al. Identification of Cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer’s patches. J Pharmacol Exp Ther 2006;319:632-9. [DOI] [PubMed] [Google Scholar]
- 31.Jin Y, Song Y, Zhu X, Zhou D, Chen C, Zhang Z, et al. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 2012;33:1573-82. [DOI] [PubMed] [Google Scholar]
- 32.Ma H, Jiang Q, Han S, Wu Y, Cui Tomshine J, Wang D, et al. Multicellular tumor spheroids as an in vivo-like tumor model for three-dimensional imaging of chemotherapeutic and nano material cellular penetration. Mol Imaging 2012;11:487–98. [PubMed] [Google Scholar]
- 33.Gibot L, Lemelle A, Till U, Moukarzel B, Mingotaud AF, Pimienta V, et al. Polymeric micelles encapsulating photosensitizer: Structure/photodynamic therapy efficiency relation. Biomacromolecules 2014;15:1443-55. [DOI] [PubMed] [Google Scholar]
- 34.George I, Vranic S, Boland S, Courtois A, Baeza-Squiban A. Development of an in vitro model of human bronchial epithelial barrier to study nanoparticle translocation. Toxicol In Vitro 2015;29:51-8. [DOI] [PubMed] [Google Scholar]
- 35.Schimpel C, Teubl B, Absenger M, Meindl C, Fröhlich E, Leitinger G, et al. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles. Mol Pharm 2014;11:808-18. [DOI] [PubMed] [Google Scholar]
- 36.Da Silva-Candal A, Brown T, Krishnan V, Lopez-Loureiro I, Ávila-Gómez P, Pusuluri A, et al. Shape Effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions. J Control Release 2019;309:94-105. [DOI] [PubMed] [Google Scholar]
- 37.Belli V, Guarnieri D, Biondi M, Della Sala F, Netti PA. Dynamics of nanoparticle diffusion and uptake in three-dimensional cell cultures. Colloids Surf B Biointerfaces 2017;149:7– 15. [DOI] [PubMed] [Google Scholar]
- 38.Priwitaningrum DL, Blondé JBG, Sridhar A, van Baarlen J, Hennink WE, Storm G, et al. Tumor stroma-containing 3D Spheroid arrays: A Tool to study nanoparticle penetration. J Control Release 2016;244:257-68. [DOI] [PubMed] [Google Scholar]
- 39.Albanese A, Lam AK, Sykes EA, Rocheleau JV, Chan WCW. Tumour-on-a-chip provides an optical window into nanoparticle tissue transport. Nat Commun 2013;4:2718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Chen Y, Gao D, Wang Y, Lin S, Jiang Y. A novel 3D breast-cancer- on-chip platform for therapeutic evaluation of drug delivery systems. Anal Chim Acta 2018;1036:97-106. [DOI] [PubMed] [Google Scholar]
- 41.Huang K, Boerhan R, Liu C, Jiang G. Nanoparticles penetrate into the multicellular spheroid-on-chip: Effect of surface charge, protein corona, and exterior flow. Mol Pharm 2017;14:4618-27. [DOI] [PubMed] [Google Scholar]
- 42.Cantisani M, Guarnieri D, Biondi M, Belli V, Profeta M, Raiola L, et al. Biocompatible nanoparticles sensing the matrix metallo- proteinase 2 for the on-demand release of anticancer drugs in 3D tumor spheroids. Colloids Surf B Biointerfaces 2015;135:707-16. [DOI] [PubMed] [Google Scholar]
- 43.Moreira AF, Dias DR, Costa EC, Correia IJ. Thermo- and PHresponsive nano-in-micro particles for combinatorial drug delivery to cancer cells. Eur J Pharm Sci 2017;104:42–51. [DOI] [PubMed] [Google Scholar]
- 44.Hou X, Liu S, Wang M, Wiraja C, Huang W, Chan P, et al. Layer-by-layer 3D constructs of fibroblasts in hydrogel for examining transdermal penetration capability of nanoparticles. SLAS Technol 2017;22:447-53. [DOI] [PubMed] [Google Scholar]
- 45.Papademetriou I, Vedula E, Charest J, Porter T. Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier. PLoS One 2018;13:e0205158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Lee SWL, Campisi M, Osaki T, Possenti L, Mattu C, Adriani G, et al. Modeling nanocarrier transport across a 3D in vitro human blood-brain–barrier microvasculature. Adv Healthc Mater 2020;9:1901486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Carvalho MR, Barata D, Teixeira LM, Giselbrecht S, Reis RL, Oliveira JM, et al. Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine. Sci Adv 2019;5:eaaw1317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Hanada S, Fujioka K, Inoue Y, Kanaya F, Manome Y, Yamamoto K. Cell-based in vitro blood–brain barrier model can rapidly evaluate nanoparticles’ brain permeability in association with particle size and surface modification. Int J Mol Sci 2014;15:1812-25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Kim TH, Mount CW, Gombotz WR, Pun SH. The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles. Biomaterials 2010;31:7386-97. [DOI] [PubMed] [Google Scholar]
- 50.Goodman TT, Olive PL, Pun SH. Increased nanoparticle penetration in collagenase-treated multicellular spheroids. Int J Nanomedicine 2007;2:265-74. [PMC free article] [PubMed] [Google Scholar]
- 51.Kim Y, Lobatto ME, Kawahara T, Lee Chung B, Mieszawska AJ, Sanchez-Gaytan BL, et al. Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis. Proc Natl Acad Sci USA 2014;111:1078-83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Thomsen TB, Li L, Howard KA. Mucus barrier-triggered disassembly of SiRNA nanocarriers. Nanoscale 2014;6-12547-54. [DOI] [PubMed] [Google Scholar]
- 53.Carvalho VFM, Migotto A, Giacone DV, de Lemos DP, Zanoni TB, Maria-Engler SS, et al. Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve colocalization in the skin and potentiate cytotoxic effects in 2D and 3D models. Eur J Pharm Sci 2017;109:131-43. [DOI] [PubMed] [Google Scholar]
- 54.Jia Z, Guo Z, Yang CT, Prestidge C, Thierry B. “Mucus-onchip”: A new tool to study the dynamic penetration of nanoparticulate drug carriers into mucus. Int J Pharm 2021;598120391. [DOI] [PubMed] [Google Scholar]
- 55.McCormick SC, Stillman N, Hockley M, Perriman AW, Hauert S. Measuring nanoparticle penetration through bio-mimetic gels. Int J Nanomedicine 2021;16:2585-95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Kiew SF, Ho YT, Kiew LV, Kah JCY, Lee HB, Imae T, et al. Preparation and Characterization of an amylase-triggered dextrin- linked graphene oxide anticancer drug nanocarrier and its vascular permeability. Int J Pharm 2017;534:297-307. [DOI] [PubMed] [Google Scholar]
- 57.Ho YT, Adriani G, Beyer S, Nhan PT, Kamm RD, Kah JCY. A Facile method to probe the vascular permeability of nanoparticles in nanomedicine applications. Sci Rep 2017;7:707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Ho DN, Kohler N, Sigdel A, Kalluri R, Morgan JR, Xu C, et al. Penetration of endothelial cell coated multicellular tumor spheroids by iron oxide nanoparticles. Theranostics 2012;2:66-75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Zhang M, Xu C, Jiang L, Qin J. A 3D human lung-on-a-chip model for nanotoxicity testing. Toxicol Res (Camb) 2018;7:1048-60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Brancato V, Gioiella F, Profeta M, Imparato G, Guarnieri D, Urciuolo F, et al. 3D Tumor microtissues as an in vitro testing platform for microenvironmentally-triggered drug delivery systems. Acta Biomater 2017;57:47-58. [DOI] [PubMed] [Google Scholar]
- 61.Moore TL, Hauser D, Gruber T, Rothen-Rutishauser B, Lattuada M, Petri-Fink A, et al. Cellular shuttles: Monocytes/macrophages exhibit transendothelial transport of nanoparticles under physiological flow. ACS Appl Mater Interfaces 2017;9:18501-11. [DOI] [PubMed] [Google Scholar]
- 62.Hudecz D, Khire T, Chung HL, Adumeau L, Glavin D, Luke E, et al. Ultrathin silicon membranes for in situ optical analysis of nanoparticle translocation across a human blood–brain barrier model. ACS Nano 2020;14:1111-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Brun E, Barreau F, Veronesi G, Fayard B, Sorieul S, Chanéac C, et al. Titanium dioxide nanoparticle impact and translocation through ex vivo, in vivo and in vitro gut epithelia. Part Fibre Toxicol 2014;11:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Brandenberger C, Rothen-Rutishauser B, Mühlfeld C, Schmid O, Ferron GA, Maier KL, et al. Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. Toxicol Appl Pharmacol 2010;242:56–65. [DOI] [PubMed] [Google Scholar]
- 65.Raemy DO, Limbach LK, Rothen-Rutishauser B, Grass RN, Gehr P, Birbaum K, et al. Cerium oxide nanoparticle uptake kinetics from the gas-phase into lung cells in vitro is transport limited. Eur J Pharm Biopharm 2011;77:368-75. [DOI] [PubMed] [Google Scholar]
- 66.Yang Y, Yang X, Zou J, Jia C, Hu Y, Du H, et al. Evaluation of photodynamic therapy efficiency using an in vitro three-dimensional microfluidic breast cancer tissue model. Lab Chip. 2015,15:735-44. [DOI] [PubMed] [Google Scholar]
- 67.Wang HF, Liu Y, Wang T, Yang G, Zeng B, Zhao CX. Tumormicroenvironment- on-a-chip for evaluating nanoparticle-loaded macrophages for drug delivery. ACS Biomater Sci Eng 2020;6:5040-50. [DOI] [PubMed] [Google Scholar]
- 68.Han B, Fang WH, Zhao S, Yang Z, Hoang BX. Zinc sulfide nanoparticles improve skin regeneration. Nanomedicine 2020;29:102263. [DOI] [PubMed] [Google Scholar]
- 69.Hao F, Jin X, Liu QS, Zhou Q, Jiang G. Epidermal penetration of gold nanoparticles and its underlying mechanism based on human reconstructed 3D Episkin model. ACS Appl Mater Interfaces 2017;9:42577-88. [DOI] [PubMed] [Google Scholar]
- 70.Englert C, Trützschler AK, Raasch M, Bus T, Borchers P, Mosig AS, et al. Crossing the blood-brain barrier: Glutathione-conjugated poly(ethylene imine) for gene delivery. J Control Release 2016;241:1–14. [DOI] [PubMed] [Google Scholar]
- 71.Küchler S, Wolf NB, Heilmann S, Weindl G, Helfmann J, Yahya MM, et al. 3D-wound healing model: Influence of Morphine and solid lipid nanoparticles. J Biotechnol 2010;148:24–30. [DOI] [PubMed] [Google Scholar]
- 72.Giacone DV, Dartora VFMC, de Matos JKR, Passos JS, Miranda DAG, de Oliveira EA, et al. Effect of Nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D Skin cancer models. Int J Biol Macromol 2020;165:1055–65. [DOI] [PubMed] [Google Scholar]
- 73.Jun SH, Kim H, Lee H, Song JE, Park SG, Kang NG. Synthesis of retinol-loaded lipid nanocarrier via vacuum emulsification to improve topical skin delivery. Polymers (Basel) 2021;13:826. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Wang A, Weldrick PJ, Madden LA, Paunov VN. Biofilm- Infected human clusteroid three-dimensional coculture platform to replace animal models in testing antimicrobial nanotechnologies. ACS Appl Mater Interfaces 2021;13:22182–94. [DOI] [PubMed] [Google Scholar]
